fangchinoline has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, Y; Pang, D; Xing, Z; Yang, Y; Zhang, X; Zhang, Y | 1 |
| Bu, YQ; Hu, N; Liu, GL; Liu, XJ; Song, FZ; Wan, JY; Wang, CD; Wu, XM; Yuan, CF; Zhang, L; Zu, Y | 1 |
2 other study(ies) available for fangchinoline and cyclin d1
| Article | Year |
|---|---|
Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin D3; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; G1 Phase; Humans; Oncogene Proteins | 2013 |
Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
Topics: Apoptosis; Benzylisoquinolines; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cyclin D1; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2014 |